Last Close
27.13
Jul 20 • 03:59PM ET Dollar change-2.05 Percentage change(-7.03%)
Aftermarket Close
27.07
Aftermarket • 07:56PM ET Dollar change-0.06 Percentage change(-0.22%)
Index
-
Market Cap
550.04M
Enterprise Value
-
Income
-
Sales
-
Book/sh
-
Cash/sh
-
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
-
IPO
May 11, 2026
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
-
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
-
Insider Trans
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-15.99%
SMA50
-13.62%
SMA200
-13.62%
Trades
Shs Outstand
20.27M
Shs Float
-
52W High
59.00 -54.02%
52W Low
19.20 41.30%
Volatility
12.91% 14.58%
ATR (14)
5.05
RSI (14)
41.08
Beta
-
Rel Volume
0.58
Avg Volume
808.56K
Volume
467,199
Perf Week
-16.32%
Perf Month
-16.16%
Perf Quarter
-
Perf Half Y
-
Perf YTD
-54.02%
Perf Year
-
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
29.18
Price
27.13
Change
-7.03%
Jul-15-26 08:56AM
Jul-08-26 08:30AM
Jun-29-26 08:40AM
Jun-26-26 09:00AM
Jun-24-26 09:20AM
08:00AM Loading…
Jun-18-26 08:00AM
Jun-11-26 08:00AM
Jun-04-26 10:01AM
Jun-03-26 05:42AM
May-20-26 09:00AM
May-15-26 08:30AM
May-11-26 07:00AM
RoboStrategy, Inc. is a non-diversified, closed-end management investment company, which engages in investing in equity and equity-linked securities of private and public companies operating in the fields of robotics and embodied artificial intelligence. The company was founded on May 23, 2025 and is headquartered in San Juan, Puerto Rico.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kang Andrew KaiPresidentJul 14 '26Buy36.71272,4059,999,9882,027,687Jul 15 05:12 PM
Last Close
0.8386
Jul 20 • 03:59PM ET Dollar change-0.0414 Percentage change(-4.70%)
Aftermarket Close
0.8439
Aftermarket • 07:59PM ET Dollar change+0.0053 Percentage change(0.63%)
CRDF Cardiff Oncology Inc daily Stock Chart
Index
-
Market Cap
57.34M
Enterprise Value
11.93M
Income
-44.79M
Sales
0.53M
Book/sh
0.51
Cash/sh
0.67
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
31
IPO
Jul 27, 2004
P/E
-
Forward P/E
-
PEG
-
P/S
108.19
P/B
1.65
P/C
1.24
P/FCF
-
EV/EBITDA
-
EV/Sales
22.51
Quick Ratio
3.27
Current Ratio
3.27
Debt/Eq
0.02
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-0.67
EPS next Y
-0.82
EPS next Q
-0.12
EPS this Y
1.32%
EPS next Y
-20.42%
EPS next 5Y
-17.89%
EPS past 3/5Y
8.24% 8.71%
Sales past 3/5Y
15.39% 10.13%
EPS Y/Y TTM
28.59%
Sales Y/Y TTM
-10.71%
EPS Q/Q
10.54%
Sales Q/Q
-62.39%
Insider Own
9.60%
Insider Trans
15.33%
Inst Own
30.02%
Inst Trans
-4.05%
ROA
-66.82%
ROE
-84.79%
ROIC
-128.96%
Gross Margin
-70.86%
Oper. Margin
-9033.90%
Profit Margin
-8530.86%
SMA20
-30.38%
SMA50
-41.92%
SMA200
-56.72%
Trades
Shs Outstand
68.37M
Shs Float
61.81M
52W High
4.55 -81.59%
52W Low
0.83 1.04%
Volatility
9.40% 8.40%
ATR (14)
0.13
RSI (14)
26.81
Beta
1.50
Rel Volume
1.27
Avg Volume
1.46M
Volume
1,849,465
Perf Week
-37.88%
Perf Month
-28.93%
Perf Quarter
-53.41%
Perf Half Y
-69.94%
Perf YTD
-70.16%
Perf Year
-80.41%
Perf 3Y
-43.72%
Perf 5Y
-85.39%
Perf 10Y
-99.77%
Prev Close
0.88
Price
0.84
Change
-4.70%
Date Action Analyst Rating Change Price Target Change
Jun-03-26Downgrade Craig Hallum Buy → Hold $2
Jun-01-26Downgrade TD Cowen Buy → Hold
Jun-01-26Downgrade H.C. Wainwright Buy → Neutral
Jan-05-26Initiated Noble Capital Markets Outperform $12
Jul-08-25Initiated Ladenburg Thalmann Buy $19
Jun-24-25Initiated Jefferies Hold $3.50
Sep-06-24Initiated Craig Hallum Buy $8
Jan-05-22Initiated William Blair Outperform
Dec-08-21Initiated Robert W. Baird Outperform $19
Aug-09-21Resumed Maxim Group Buy $30 → $20
Jul-15-26 10:54AM
08:00AM
Jun-02-26 09:06AM
Jun-01-26 04:01PM
May-21-26 05:00PM
04:22PM Loading…
May-14-26 04:22PM
04:10PM
Apr-28-26 04:01PM
Apr-27-26 07:00AM
Apr-21-26 10:00AM
Apr-17-26 04:01PM
Apr-09-26 04:01PM
Mar-27-26 08:05AM
Mar-20-26 07:00AM
Mar-19-26 07:00AM
04:01PM Loading…
Feb-26-26 04:01PM
04:32AM
Feb-24-26 05:26PM
04:30PM
Feb-19-26 07:00AM
Jan-28-26 06:23AM
Jan-27-26 10:54AM
07:05AM
07:00AM
Dec-08-25 04:05PM
07:00AM
Nov-24-25 07:00AM
Nov-06-25 04:33PM
04:05PM
Nov-04-25 04:01PM
04:05PM Loading…
Oct-02-25 04:05PM
Aug-28-25 04:05PM
Jul-29-25 05:25PM
04:23PM
04:07PM
04:05PM
Jun-19-25 09:25AM
09:25AM
Jun-17-25 04:05PM
Jun-02-25 04:05PM
May-14-25 12:00PM
May-08-25 05:25PM
04:05PM
May-02-25 03:35AM
Apr-28-25 10:00AM
Apr-24-25 10:01AM
Apr-23-25 04:05PM
04:05PM
Apr-15-25 04:10PM
04:05PM
Mar-26-25 03:57PM
Mar-08-25 07:33AM
Feb-27-25 04:05PM
Feb-26-25 08:12AM
Feb-24-25 04:05PM
Feb-20-25 04:05PM
Dec-26-24 09:00AM
Dec-20-24 12:52PM
Dec-18-24 11:12AM
Dec-14-24 06:50AM
Dec-11-24 07:19AM
Dec-10-24 07:20AM
06:00AM
Nov-19-24 08:00AM
Nov-07-24 04:05PM
Oct-30-24 04:30PM
Aug-08-24 04:05PM
Aug-01-24 04:05PM
May-29-24 04:05PM
May-13-24 04:05PM
May-09-24 12:15PM
May-07-24 06:00AM
May-02-24 09:54PM
05:45PM
04:05PM
Apr-25-24 04:05PM
Apr-08-24 04:05PM
Apr-01-24 08:50AM
Mar-21-24 07:55AM
Mar-14-24 08:50AM
08:08AM
Mar-06-24 04:05PM
12:00PM
Mar-01-24 10:12AM
Feb-29-24 07:40PM
04:07PM
04:06PM
04:05PM
Feb-26-24 08:00AM
Feb-22-24 08:00AM
Jan-17-24 10:30AM
Nov-20-23 04:05PM
Nov-02-23 04:05PM
Oct-26-23 04:05PM
Oct-23-23 08:45AM
Oct-11-23 09:35AM
Sep-26-23 04:05PM
Sep-05-23 08:00AM
Aug-09-23 04:05PM
Aug-07-23 04:05PM
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. Its clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.
PresidentDr. Mani Mohindru Ph.D.
M.D.Dr. Roger Sidhu FRCPC
M.B.A.Mr. Josh Muntner BFA
M.D.Dr. Ajay Aggarwal M.B.A.
Chief Accounting OfficerMs. Brigitte Lindsay
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PACE GARY WDirectorJul 14 '26Buy1.46687,2851,000,0002,043,661Jul 16 04:03 PM
Mohindru ManiChief Executive OfficerJul 14 '26Buy1.4634,36450,00059,067Jul 16 04:01 PM
Mohindru ManiChief Executive OfficerJun 18 '26Buy1.2124,70329,89124,703Jun 22 09:00 AM
PACE GARY WDirectorJun 18 '26Buy1.2230,00036,6001,356,376Jun 22 09:00 AM
PACE GARY WDirectorJul 30 '25Buy2.45275,000673,7501,330,676Jul 31 04:05 PM
PACE GARY WDirectorJul 30 '25Buy2.4515,00036,7501,345,676Jul 31 04:05 PM
Last Close
382.23
Jul 20 • 03:59PM ET Dollar change+9.12 Percentage change(2.44%)
Aftermarket Close
384.96
Aftermarket • 07:47PM ET Dollar change+2.73 Percentage change(0.71%)
ELV Elevance Health Inc daily Stock Chart
Index
S&P 500
Market Cap
82.89B
Enterprise Value
-
Income
4.96B
Sales
201.11B
Book/sh
206.99
Cash/sh
-
Employees
97100
IPO
Oct 30, 2001
P/E
16.99
Forward P/E
12.92
PEG
3.30
P/S
0.41
P/B
1.85
P/C
-
P/FCF
13.18
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
1.52
Debt/Eq
0.69
LT Debt/Eq
0.68
Option/Short
Yes / Yes
EPS (ttm)
22.50
EPS next Y
29.58
EPS next Q
4.75
EPS this Y
-10.44%
EPS next Y
9.03%
EPS next 5Y
3.92%
EPS past 3/5Y
1.27% 6.99%
Sales past 3/5Y
8.34% 10.32%
EPS Y/Y TTM
-4.37%
Sales Y/Y TTM
6.27%
EPS Q/Q
-13.02%
Sales Q/Q
1.40%
Insider Own
0.30%
Insider Trans
0.22%
Inst Own
93.95%
Inst Trans
-2.45%
ROA
4.00%
ROE
11.20%
ROIC
6.57%
Gross Margin
-
Oper. Margin
3.63%
Profit Margin
2.47%
SMA20
-4.63%
SMA50
-4.01%
SMA200
9.28%
Trades
Shs Outstand
216.84M
Shs Float
216.22M
52W High
436.24 -12.38%
52W Low
273.71 39.65%
Volatility
4.55% 3.08%
ATR (14)
14.90
RSI (14)
42.82
Beta
0.69
Rel Volume
0.97
Avg Volume
1.80M
Volume
1,743,600
Perf Week
-10.10%
Perf Month
-2.31%
Perf Quarter
18.32%
Perf Half Y
0.08%
Perf YTD
9.04%
Perf Year
37.94%
Perf 3Y
-19.66%
Perf 5Y
-1.98%
Perf 10Y
182.15%
Prev Close
373.11
Price
382.23
Change
2.44%
Date Action Analyst Rating Change Price Target Change
May-20-26Upgrade Deutsche Bank Hold → Buy $498
Apr-29-26Upgrade BofA Securities Neutral → Buy $435
Apr-08-26Initiated Evercore ISI In-line $345
Feb-03-26Downgrade RBC Capital Mkts Outperform → Sector Perform $358
Jan-08-26Upgrade Wolfe Research Peer Perform → Outperform $425
Dec-19-25Downgrade Deutsche Bank Buy → Hold $320
Oct-14-25Initiated Goldman Neutral
Jul-21-25Downgrade Argus Buy → Hold
Jul-18-25Downgrade Leerink Partners Outperform → Market Perform $310
Apr-15-25Downgrade Robert W. Baird Outperform → Neutral $529
Today 10:43AM
Jul-17-26 06:20PM
06:09PM
06:02PM
Jul-16-26 10:54AM
09:19AM Loading…
09:19AM
08:30AM
08:30AM
Jul-15-26 05:00PM
04:30PM
09:36AM
08:59AM
08:29AM
07:21AM
06:48AM
06:44AM Loading…
06:44AM
06:10AM
06:00AM
Jul-14-26 06:07PM
Jul-13-26 01:54PM
03:00AM
Jul-10-26 07:55AM
Jul-09-26 09:47AM
Jul-06-26 04:30PM
12:11PM
Jul-03-26 08:20AM
Jul-02-26 10:46AM
Jul-01-26 04:30PM
Jun-30-26 08:49AM
Jun-17-26 10:00AM
05:30AM Loading…
05:30AM
Jun-16-26 11:44AM
Jun-05-26 04:20PM
Jun-04-26 12:38PM
Jun-01-26 04:54AM
May-20-26 09:43AM
09:35AM
May-07-26 08:47PM
May-04-26 02:10PM
Apr-30-26 08:00AM
Apr-29-26 02:06PM
09:42AM
07:34AM
Apr-23-26 08:03AM
03:02AM
Apr-22-26 12:45PM
07:55AM
06:07AM
06:00AM
Apr-21-26 09:17AM
Apr-14-26 04:59AM
Apr-11-26 08:16AM
Apr-08-26 09:42AM
Apr-07-26 06:03PM
11:04AM
09:48AM
04:36AM
Apr-06-26 05:51PM
04:58PM
Apr-02-26 11:54AM
Apr-01-26 06:33AM
Mar-31-26 09:00AM
04:58AM
Mar-30-26 04:30PM
Mar-29-26 10:29AM
Mar-10-26 01:41PM
Mar-09-26 11:56AM
Mar-03-26 10:00AM
04:25AM
Mar-02-26 05:05PM
04:38PM
04:37PM
04:01PM
01:19PM
12:30PM
12:12PM
11:19AM
10:53AM
09:25AM
07:35AM
Feb-27-26 05:45AM
Feb-26-26 03:02PM
Feb-25-26 12:42PM
12:14PM
Feb-24-26 10:06AM
08:45AM
Feb-20-26 11:55AM
Feb-19-26 04:02PM
Feb-18-26 04:50PM
07:09AM
Feb-17-26 06:01PM
Feb-15-26 11:40PM
Feb-11-26 11:02PM
09:47AM
07:04AM
Feb-10-26 05:15PM
12:31PM
08:00AM
Feb-09-26 02:08PM
Feb-06-26 01:32PM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
PresidentMs. Gail Koziara Boudreaux
Executive VP & CFOMr. Mark Bradley Kaye
Special AdvisorMr. Peter David Haytaian Esq.
EVP and President of Commercial & Specialty Health BenefitsMr. Charles Morgan Kendrick Jr.
Executive VP & Chief Health Benefits OfficerMs. Felicia Farr Norwood
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PERU RAMIRO GDirectorJul 17 '26Buy366.051,000366,05010,908Jul 17 03:04 PM
BOUDREAUX GAILPresident and CEOJul 17 '26Buy367.792,7251,002,230171,976Jul 17 01:50 PM
CLARK R KERRYDirectorJul 07 '26Proposed Sale419.911,500629,865Jul 07 04:58 PM
Penczek Ronald WCAO & ControllerJun 12 '26Sale403.16369148,7663,740Jun 15 04:10 PM
RONALD WILLIAM PENCZEKOfficerJun 12 '26Proposed Sale403.16369148,767Jun 12 05:27 PM
Dixon Robert L JRDirectorJun 11 '26Sale401.7715160,66710,734Jun 12 04:12 PM
Dixon Robert L JRDirectorJun 11 '26Proposed Sale401.7615160,666Jun 11 05:10 PM
Penczek Ronald WCAO & ControllerMay 19 '26Option Exercise294.301,531450,5795,640May 20 04:11 PM
Penczek Ronald WCAO & ControllerMay 19 '26Sale403.131,531617,1924,109May 20 04:11 PM
RONALD WILLIAM PENCZEKOfficerMay 19 '26Proposed Sale403.131,531617,192May 19 04:25 PM
SCHULMAN AMY WDirectorMar 12 '26Sale287.50267,475218Mar 23 04:10 PM
Kendrick Charles Morgan JREVP & President, CommercialMar 06 '26Sale284.923,196910,60411,791Mar 09 04:45 PM
CHARLES MORGAN KENDRICKOfficerMar 06 '26Proposed Sale284.923,196910,593Mar 06 04:17 PM
COLLIS STEVEN HDirectorMar 05 '26Buy289.843,000869,5203,639Mar 06 08:03 AM
DeVore Susan D.DirectorAug 19 '25Buy312.151,200374,5803,502Aug 21 04:20 PM
Last Close
7.35
Jul 20 • 03:59PM ET Dollar change+0.01 Percentage change(0.14%)
Aftermarket Close
7.35
Aftermarket • 07:34PM ET Dollar change0.00 Percentage change(0.00%)
LILA Liberty Latin America Ltd daily Stock Chart
Index
RUT
Market Cap
1.48B
Enterprise Value
10.15B
Income
-497.50M
Sales
4.44B
Book/sh
2.69
Cash/sh
3.39
Employees
9000
IPO
Jun 22, 2015
P/E
-
Forward P/E
25.83
PEG
-
P/S
0.33
P/B
2.74
P/C
2.17
P/FCF
4.53
EV/EBITDA
6.24
EV/Sales
2.29
Quick Ratio
1.11
Current Ratio
1.11
Debt/Eq
16.43
LT Debt/Eq
15.35
Option/Short
Yes / Yes
EPS (ttm)
-2.49
EPS next Y
0.28
EPS next Q
-0.00
EPS this Y
95.57%
EPS next Y
409.16%
EPS next 5Y
-
EPS past 3/5Y
-58.68% 2.57%
Sales past 3/5Y
-2.61% 3.37%
EPS Y/Y TTM
38.27%
Sales Y/Y TTM
0.01%
EPS Q/Q
83.59%
Sales Q/Q
-0.06%
Insider Own
84.71%
Insider Trans
1.98%
Inst Own
14.49%
Inst Trans
-2.50%
ROA
-4.02%
ROE
-63.68%
ROIC
-5.63%
Gross Margin
57.85%
Oper. Margin
16.51%
Profit Margin
-11.20%
SMA20
1.64%
SMA50
21.66%
SMA200
31.60%
Trades
Shs Outstand
37.80M
Shs Float
30.80M
52W High
8.10 -9.32%
52W Low
4.32 70.05%
Volatility
3.58% 6.21%
ATR (14)
0.33
RSI (14)
60.93
Beta
0.68
Rel Volume
0.74
Avg Volume
769.96K
Volume
567,464
Perf Week
-1.87%
Perf Month
38.68%
Perf Quarter
25.71%
Perf Half Y
44.70%
Perf YTD
46.46%
Perf Year
68.33%
Perf 3Y
26.44%
Perf 5Y
-22.02%
Perf 10Y
-67.70%
Prev Close
7.34
Price
7.35
Change
0.14%
Date Action Analyst Rating Change Price Target Change
Feb-25-25Downgrade Barclays Equal Weight → Underweight $8 → $6.50
Sep-27-23Upgrade Scotiabank Sector Underperform → Sector Perform $8.70
May-31-23Initiated Goldman Buy $10
Jun-03-22Downgrade Scotiabank Sector Perform → Sector Underperform
Apr-16-21Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-05-20Downgrade Scotiabank Sector Perform → Sector Underperform $6.50
Oct-15-20Reiterated The Benchmark Company Buy $17 → $19
Oct-09-20Upgrade Morgan Stanley Equal-Weight → Overweight $11
Mar-12-20Upgrade HSBC Securities Hold → Buy $17.50
Oct-17-19Upgrade Barclays Underweight → Equal Weight $18 → $20
Jun-01-26 05:45PM
09:00AM
May-21-26 09:06AM
May-18-26 10:41AM
09:15AM
07:00AM Loading…
May-07-26 07:00AM
May-06-26 04:30PM
Apr-30-26 04:30PM
Feb-19-26 04:02PM
10:27AM
08:30AM
Feb-18-26 05:00PM
Feb-17-26 04:53PM
09:00AM
Feb-13-26 04:00AM
04:15PM Loading…
Feb-12-26 04:15PM
09:44AM
Dec-19-25 09:00AM
Nov-13-25 09:15AM
Nov-06-25 04:15PM
Nov-05-25 04:51PM
Oct-31-25 01:22PM
Oct-29-25 04:30PM
03:45PM
Sep-25-25 08:30AM
Aug-26-25 10:03AM
Aug-07-25 07:00AM
Aug-05-25 06:02AM
Jul-30-25 04:30PM
Jul-28-25 05:51PM
04:15PM Loading…
Jul-15-25 04:15PM
Jun-30-25 11:00AM
May-09-25 12:01PM
03:19AM
May-07-25 04:45PM
10:23AM
Apr-30-25 04:30PM
Apr-09-25 08:00AM
Mar-22-25 01:25AM
Mar-03-25 09:15AM
Feb-21-25 02:07AM
Feb-19-25 04:40PM
Feb-13-25 08:07AM
Feb-12-25 04:15PM
Feb-11-25 09:00AM
Feb-10-25 05:49PM
Feb-04-25 04:31PM
Jan-08-25 04:35AM
Dec-09-24 07:37PM
Dec-05-24 12:38PM
Nov-19-24 08:24AM
Nov-06-24 04:45PM
Oct-29-24 04:15PM
Oct-16-24 09:00AM
Sep-26-24 10:04AM
Sep-20-24 09:40AM
Sep-18-24 08:33AM
Sep-04-24 09:00AM
Aug-23-24 09:40AM
Aug-06-24 04:55PM
Aug-01-24 09:00AM
Jul-30-24 04:17PM
Jul-10-24 07:52AM
07:52AM
Jun-24-24 09:00AM
Jun-14-24 04:32AM
Jun-07-24 11:44AM
May-30-24 11:17AM
May-13-24 09:22AM
May-09-24 09:56AM
12:15AM
May-08-24 02:51PM
May-07-24 10:53PM
10:53PM
06:33PM
04:45PM
11:41AM
Apr-30-24 09:00AM
Apr-09-24 11:14AM
Mar-28-24 11:54AM
Mar-25-24 02:26PM
Mar-22-24 07:02PM
Mar-20-24 12:51PM
Mar-08-24 11:50AM
Mar-06-24 07:37AM
Mar-05-24 05:51AM
Feb-27-24 08:14AM
Feb-24-24 01:12AM
Feb-22-24 05:12PM
04:38PM
Feb-16-24 04:30PM
Jan-19-24 09:13AM
Jan-03-24 06:38AM
Dec-05-23 01:02PM
Nov-28-23 04:03AM
Nov-27-23 10:41AM
Nov-26-23 09:40AM
Nov-24-23 03:59AM
Nov-13-23 11:40AM
Nov-11-23 12:04AM
Liberty Latin America Ltd. is a holding company, which engages in the provision of fixed, mobile, and subsea telecommunications services. It operates through the following segments: C and W Carribean, C and W Panama, Liberty Networks, Liberty Puerto Rico, Liberty Costa Rica, and VTR. The company was founded in 1999 and is headquartered in Denver, CO.
Executive ChairmanMr. Michael Thomas Fries
PresidentMr. Balan Nair
Senior VP & CFOMr. Christopher J. Noyes
Senior VP and Chief Technology & Product OfficerMr. Aamir M. Hussain
Senior VPMr. John M. Winter
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FRIES MICHAEL TExecutive ChairmanJun 25 '26Buy20.3949,3821,006,711149,335Jul 17 08:11 PM
WINTER JOHN MSVP, CLO AND SECRETARYJun 26 '26Buy19.675,07199,73864,547Jun 30 05:06 PM
MALONE JOHN CDirector EmeritusJun 25 '26Buy6.96336,7062,343,9793,708,120Jun 29 05:27 PM
MALONE JOHN CDirector EmeritusJun 25 '26Buy20.4545,300926,3261,261,922Jun 29 05:27 PM
MALONE JOHN CDirector EmeritusJun 26 '26Buy7.0017,693123,8193,725,813Jun 29 05:27 PM
BRACKEN CHARLES H RDirectorJun 24 '26Buy20.504,900100,45023,767Jun 25 06:18 PM
BRACKEN CHARLES H RDirectorJun 23 '26Buy20.504,900100,45018,867Jun 25 06:18 PM
MALONE JOHN CDirector EmeritusJun 23 '26Buy20.36479,1019,755,9881,017,272Jun 24 08:00 PM
MALONE JOHN CDirector EmeritusJun 22 '26Buy4.981,319,1816,564,48721,397,127Jun 24 08:00 PM
MALONE JOHN CDirector EmeritusJun 22 '26Buy19.89260,2995,177,920538,171Jun 24 08:00 PM
MALONE JOHN CDirector EmeritusJun 24 '26Buy20.39199,3504,065,5841,216,622Jun 24 08:00 PM
MALONE JOHN CDirector EmeritusJun 23 '26Buy5.92400,0002,368,0803,371,414Jun 24 08:00 PM
Nair BalanPresident and CEOJun 18 '26Buy6.07164,9141,000,9723,276,798Jun 23 05:08 PM
PADDICK BRENDAN JDirectorJun 18 '26Buy4.88100,000488,2001,559,542Jun 23 05:07 PM
MALONE JOHN CDirector EmeritusMay 22 '26Buy8.6312,406,463107,067,77621,173,018May 27 04:33 PM
MALONE JOHN CDirector EmeritusMay 22 '26Sale8.6312,406,463107,067,7760May 27 04:33 PM
Nair BalanPresident and CEOMay 08 '26Buy8.0720,000161,4903,125,039May 12 05:29 PM
FRIES MICHAEL TExecutive ChairmanMar 15 '26Option Exercise0.0071,0340541,436Mar 17 05:47 PM
BRACKEN CHARLES H RDirectorMar 15 '26Option Exercise0.0022,431014,954Mar 17 05:46 PM
DE ANGOITIA ALFONSODirectorMar 15 '26Option Exercise0.0022,4310100,476Mar 17 05:46 PM
GOULD PAUL ADirectorMar 15 '26Option Exercise0.003,3660452,185Mar 17 05:46 PM
PADDICK BRENDAN JDirectorMar 15 '26Option Exercise0.0022,43101,982,988Mar 17 05:45 PM
Sanchez Daniel E.DirectorMar 15 '26Option Exercise0.0022,431059,713Mar 17 05:45 PM
Jacobson Roberta S.DirectorMar 15 '26Option Exercise0.003,366029,648Mar 17 05:44 PM
CURTIS MIRANDADirectorMar 15 '26Option Exercise0.0022,431083,889Mar 17 05:42 PM
ZOOK BRIAN DMD, CHIEF ACCOUNTING OFFICERFeb 20 '26Sale8.0494,494759,3406,813Feb 24 04:31 PM
Last Close
6.09
Jul 20 • 03:59PM ET Dollar change-0.08 Percentage change(-1.30%)
Aftermarket Close
6.12
Aftermarket • 05:00PM ET Dollar change+0.03 Percentage change(0.49%)
VIRC Virco Manufacturing Corp daily Stock Chart
Index
-
Market Cap
95.79M
Enterprise Value
130.82M
Income
-0.94M
Sales
196.59M
Book/sh
6.51
Cash/sh
0.24
Employees
731
IPO
Mar 08, 1977
P/E
-
Forward P/E
18.45
PEG
0.38
P/S
0.49
P/B
0.94
P/C
25.68
P/FCF
20.25
EV/EBITDA
21.20
EV/Sales
0.67
Quick Ratio
0.90
Current Ratio
2.71
Debt/Eq
0.38
LT Debt/Eq
0.31
Option/Short
Yes / Yes
EPS (ttm)
-0.06
EPS next Y
0.33
EPS next Q
0.07
EPS this Y
-93.75%
EPS next Y
3200.00%
EPS next 5Y
49.07%
EPS past 3/5Y
-45.79% -
Sales past 3/5Y
-4.75% 5.50%
EPS Y/Y TTM
-104.75%
Sales Y/Y TTM
-22.38%
EPS Q/Q
-480.39%
Sales Q/Q
-9.07%
Insider Own
16.22%
Insider Trans
1.81%
Inst Own
48.19%
Inst Trans
-3.50%
ROA
-0.52%
ROE
-0.90%
ROIC
-0.70%
Gross Margin
39.43%
Oper. Margin
0.05%
Profit Margin
-0.48%
SMA20
-2.22%
SMA50
-0.37%
SMA200
-5.43%
Trades
Shs Outstand
15.73M
Shs Float
13.17M
52W High
9.09 -32.97%
52W Low
5.16 18.14%
Volatility
2.13% 4.16%
ATR (14)
0.23
RSI (14)
47.81
Beta
0.22
Rel Volume
0.32
Avg Volume
68.33K
Volume
21,550
Perf Week
-1.14%
Perf Month
-0.65%
Perf Quarter
-4.40%
Perf Half Y
-4.40%
Perf YTD
-4.69%
Perf Year
-22.42%
Perf 3Y
41.96%
Perf 5Y
82.88%
Perf 10Y
33.85%
Prev Close
6.17
Price
6.09
Change
-1.30%
Date Action Analyst Rating Change Price Target Change
Jun-21-17Resumed Wedbush Outperform $5 → $6
Apr-20-09Reiterated Wedbush Morgan Hold $2.75 → $3
Dec-15-08Reiterated Wedbush Morgan Hold $5 → $2.75
Sep-12-08Reiterated Wedbush Morgan Hold $5.75 → $5
Dec-11-07Reiterated Wedbush Morgan Hold $8 → $7.50
Sep-12-07Reiterated Wedbush Morgan Hold $7.50 → $8
Jun-03-26 08:30AM
Apr-08-26 08:30AM
Dec-08-25 08:30AM
Sep-05-25 09:45AM
08:30AM
05:20PM Loading…
Aug-18-25 05:20PM
Aug-11-25 07:00PM
Jul-25-25 09:40AM
Jul-09-25 09:40AM
Jun-27-25 04:27AM
Jun-26-25 10:59AM
Jun-23-25 09:40AM
09:04AM
04:52AM
Jun-06-25 09:45AM
08:30AM Loading…
08:30AM
May-01-25 05:42PM
Apr-15-25 12:28PM
Apr-14-25 08:30AM
Mar-26-25 05:30PM
Jan-21-25 08:30AM
Dec-09-24 09:45AM
08:30AM
Oct-30-24 04:37PM
Sep-09-24 09:50AM
08:30AM
Aug-01-24 09:40AM
08:50AM
Jul-17-24 06:31PM
Jul-16-24 09:40AM
08:50AM Loading…
08:50AM
Jul-02-24 07:37PM
Jun-12-24 09:40AM
08:50AM
Jun-10-24 08:42AM
Jun-07-24 12:52PM
09:50AM
08:30AM
May-30-24 03:23PM
Apr-15-24 10:48AM
Apr-12-24 10:10AM
09:00AM
Apr-01-24 08:30AM
Feb-27-24 08:00AM
Jan-24-24 09:15AM
Jan-23-24 08:50AM
Jan-18-24 09:40AM
Jan-05-24 09:15AM
Jan-02-24 08:50AM
Dec-28-23 12:00PM
Dec-21-23 09:40AM
Dec-18-23 09:25AM
Dec-14-23 08:50AM
Dec-09-23 07:28PM
Dec-08-23 08:10AM
07:00AM
Oct-17-23 08:50AM
Sep-29-23 08:50AM
Sep-13-23 10:00AM
08:50AM
08:47AM
Sep-11-23 10:15AM
08:30AM
Sep-07-23 09:40AM
Aug-22-23 08:50AM
Jul-31-23 06:05AM
Jul-25-23 09:40AM
Jul-24-23 08:10AM
07:12AM
Jul-17-23 09:40AM
Jul-14-23 06:38AM
Jun-30-23 09:40AM
Jun-14-23 09:40AM
Jun-12-23 08:45AM
07:30AM
May-21-23 10:46AM
Apr-30-23 08:05AM
Apr-28-23 10:45AM
09:30AM
Mar-26-23 08:16AM
Feb-13-23 12:15PM
Jan-26-23 09:40AM
Jan-16-23 09:40AM
09:40AM
Jan-13-23 05:00AM
Jan-12-23 07:51AM
Dec-28-22 09:40AM
Dec-27-22 07:42AM
Dec-19-22 09:40AM
Dec-16-22 09:40AM
08:59AM
Dec-14-22 12:00PM
Dec-12-22 08:45AM
07:30AM
Nov-18-22 07:45AM
Nov-08-22 09:40AM
Oct-17-22 06:46AM
Oct-13-22 09:40AM
Sep-27-22 09:40AM
07:34AM
Virco Manufacturing Corp. engages in the design, production and distribution of furniture. Its products include mobile tables, mobile storage equipment, desks, computer furniture, chairs, foldable chairs and foldable tables. The company was founded in February 1950 and is headquartered in Torrance, CA.
Chairman of the Board & CEOMr. Robert A. Virtue
President & DirectorMr. Douglas A. Virtue
Senior VP of FinanceMs. Bassey Yau
VP of Sales & DirectorMs. Kathy Virtue Young
Senior VP & COOMr. J. Scott Bell
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
VIRTUE DOUGLAS AExecutive Vice PresidentJul 15 '26Buy6.005,14030,838893,808Jul 16 04:32 PM
VIRTUE DOUGLAS AExecutive Vice PresidentJul 16 '26Buy6.006003,600894,408Jul 16 04:32 PM
VIRTUE DOUGLAS AExecutive Vice PresidentJul 08 '26Buy6.008,08348,474888,663Jul 09 04:36 PM
VIRTUE DOUGLAS AExecutive Vice PresidentJul 09 '26Buy6.00530888,668Jul 09 04:36 PM
VIRTUE DOUGLAS AExecutive Vice PresidentJun 29 '26Buy6.001,4008,400880,580Jun 30 04:50 PM
VIRTUE ROBERT ACEOJun 11 '26Buy6.224,30026,758506,124Jun 15 01:29 PM
VIRTUE DOUGLAS AExecutive Vice PresidentJun 09 '26Buy6.001,3147,884879,180Jun 11 03:23 PM
VIRTUE DOUGLAS AExecutive Vice PresidentApr 15 '26Buy6.0911,67871,119877,866Apr 15 05:34 PM
VIRTUE DOUGLAS AExecutive Vice PresidentApr 14 '26Buy6.074,34926,398866,188Apr 15 05:34 PM
Lind Robert RDirectorApr 15 '26Buy6.075003,035119,890Apr 15 03:03 PM
VIRTUE ROBERT ACEOApr 14 '26Buy6.222,70016,794501,824Apr 14 02:57 PM
RICHARDSON BRADLEY CDirectorApr 10 '26Buy5.591,6008,94439,354Apr 13 04:29 PM
RICHARDSON BRADLEY CDirectorApr 13 '26Buy5.634002,25239,754Apr 13 04:29 PM
VIRTUE ROBERT ACEOApr 10 '26Buy5.523,30018,216499,124Apr 13 04:28 PM
VIRTUE ROBERT ACEOJan 13 '26Buy6.322,50015,800495,824Jan 13 05:29 PM
RICHARDSON BRADLEY CDirectorJan 07 '26Buy6.502,00013,00937,754Jan 07 04:19 PM
VIRTUE DOUGLAS AExecutive Vice PresidentOct 17 '25Buy7.3413,02295,581861,839Oct 17 05:09 PM
VIRTUE ROBERT ACEOOct 16 '25Buy6.965,00034,800493,324Oct 16 04:49 PM